Idexx Laboratories (IDXX) Gross Profit (2009 - 2026)

Idexx Laboratories (IDXX) has reported Gross Profit for 18 consecutive years, with $722.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Gross Profit rose 15.94% year-over-year to $722.7 million; the TTM figure through Mar 2026 stood at $2.8 billion (up 14.52% YoY), while the FY2025 annual figure was $2.7 billion, up 11.8% from the prior year.
• Gross Profit came in at $722.7 million for Q1 2026 at Idexx Laboratories, up from $658.1 million in the prior quarter.
• The five-year high for Gross Profit was $722.7 million in Q1 2026, with the low at $484.9 million in Q4 2022.
• Average Gross Profit over 5 years is $585.6 million, with a median of $572.8 million recorded in 2023.
• Across the five-year window, Gross Profit increased 5.05% in 2022 and rose 15.94% in 2026, its largest moves.
• Year by year, Gross Profit stood at $484.9 million in 2022, then grew by 8.5% to $526.2 million in 2023, then rose by 8.46% to $570.7 million in 2024, then advanced by 15.33% to $658.1 million in 2025, then grew by 9.82% to $722.7 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $722.7 million, $658.1 million, and $683.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.